Modification of the terms of the authorisation regarding the formulation of Maxiban® G160 (narasin and nicarbazin) for chickens for fattening. (14th November 2016)

• Record Type: Journal Article
• Authors: Rychen, Guido; Aquilina, Gabriele; Azimonti, Giovanna; Bampidis, Vasileios; de Lourdes Bastos, Maria; Bories, Georges; Chesson, Andrew; Cocconcelli, Pier Sandro; Flachowsky, Gerhard; Kolar, Boris; Kouba, Maryline; López Puente, Secundino; López‐Alonso, Marta; Mantovani, Alberto; Mayo, Baltasar; Ramos, Fernando; Saarela, Maria; Villa, Roberto Edoardo; Wallace, Robert John; Wester, Pieter; Brantom, Paul; Halle, Ingrid; van Beelen, Patrick; Holczknecht, Orsolya; Vittoria Vettori, Maria; Gropp, Jürgen
• Is Part Of: EFSA journal. Volume 14:Number 11(2016)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2016-11-14
• Subjects: Maxiban® G160 -- narasin -- nicarbazin -- Microtracer‐F‐Red -- formulation -- chickens for fattening; Food -- Europe -- Safety measures -- Periodicals; Food Safety; Food -- Safety measures; Europe; Periodicals; Periodicals; Fulltext; Government Publications, International; Internet Resources; Periodicals; Periodicals; 363.19209405
• DOI: 10.2903/j.efsa.2016.4614
• Languages: English
• ISSNs: 1831-4732

Abstract

Abstract: Following a request from European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the proposed modification of the terms of the authorisation regarding the formulation of the product Maxiban ® G160 (narasin and nicarbazin). The applicant has proposed to modify the concentration of Microtracer‐F‐Red in the additive from the currently authorised 11 g/kg to a range of 4–11 g/kg. Based on data submitted on the composition and the stability, the FEEDAP Panel concluded that the physicochemical properties of the additive were not affected by the proposed modification. Therefore, the assessment of safety and efficacy made for the former formulation with 11 g Microtracer‐F‐Red/kg is still valid for the newly applied formulation.